Julius Chapiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julius Chapiro has a total of 380 co-authors. Here are the top co-authors by number of shared publications:
- MingDe Lin
Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, USA
30 shared publications Todd Schlachter
Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut
15 shared publicationsBernhard Gebauer
Department of Radiology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany
11 shared publicationsLynn Jeanette Savic
Department of Radiology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany
10 shared publicationsJames S. Duncan
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Medicine, Liver Center, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Biomedical Engineering, School of Engineering and Applied Sciences, New Haven, CT 06520, USA
9 shared publicationsDavid C. Madoff
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Surgery, Section of Surgical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA
8 shared publications
Latest Publications
- 20 July 2026
- Published by Elsevier in Journal of Hepatology
Artificial intelligence and personalised medicine in liver cancer
- 20 July 2026
- Published by Elsevier in Journal of Hepatology
Artificial intelligence and personalised medicine in liver cancer
- 13 July 2026
- Published by Springer Nature in Abdominal Radiology
Machine learning modeling to predict HCC locations in cirrhotic patients undergoing MRI - a proof-of-concept study.
Current hepatocellular carcinoma (HCC) surveillance guidelines rely on manually defined LI-RADS (Liver Imaging Reporting and Data System) features rather than imaging data analysis. This study evaluates the feasibility of machine-learning (ML)-based image analysis frameworks to identify and localize hepatic parenchyma at elevated risk for HCC. In this retrospective study, cirrhotic patients with HCC diagnosis undergoing MRI between 2008 and 2023 were included. The analysis included negative screening MRI preceding a positive screening MRI confirming a LR-5 lesion within 18 months. Volume-of-interest (VOI) annotations of 'non-malignant' and 'malignant' liver tissue on the screening MRI were manually or automatically placed, mapped from future HCC lesion on positive screening MRI. Radiomics were extracted from these VOIs using PyRadiomics. Logistic regression (LR), random forest (RF), and eXtreme Gradient Boosting (XGB) models were trained and validated across four manual/automatic annotation combinations. Exploratory voxel-level heatmaps were generated to visualize high-risk HCC areas. Model performance was summarized using median values and 95% non-parametric confidence intervals. 121 patients (65 ± 9.56; 99 men) were included. The best model performances for LR, RF, and XGB were achieved when training and validating on manual annotations: (AUC [95% CI]: 0.75 [0.72-0.78]; 0.80 [0.78-0.81]; 0.79 [0.77-0.81], respectively). Predictions from LR-3 lesions outperformed regions without visible precursor territory (RF AUC [95% CI]: 0.86 [0.84-0.88] vs. 0.66 [0.63-0.70]). In 36 out of 121 patients (30%), heatmaps showed visually increased probability signals in the region where HCC subsequently became visible on follow-up imaging. The results demonstrate the feasibility of ML-based MRI analysis for identifying liver regions at increased risk for HCC development prior to radiologic diagnosis, particularly in the presence of precursor lesions.
- 13 July 2026
- Published by Springer Nature in Abdominal Radiology
Machine learning modeling to predict HCC locations in cirrhotic patients undergoing MRI - a proof-of-concept study.
Current hepatocellular carcinoma (HCC) surveillance guidelines rely on manually defined LI-RADS (Liver Imaging Reporting and Data System) features rather than imaging data analysis. This study evaluates the feasibility of machine-learning (ML)-based image analysis frameworks to identify and localize hepatic parenchyma at elevated risk for HCC. In this retrospective study, cirrhotic patients with HCC diagnosis undergoing MRI between 2008 and 2023 were included. The analysis included negative screening MRI preceding a positive screening MRI confirming a LR-5 lesion within 18 months. Volume-of-interest (VOI) annotations of 'non-malignant' and 'malignant' liver tissue on the screening MRI were manually or automatically placed, mapped from future HCC lesion on positive screening MRI. Radiomics were extracted from these VOIs using PyRadiomics. Logistic regression (LR), random forest (RF), and eXtreme Gradient Boosting (XGB) models were trained and validated across four manual/automatic annotation combinations. Exploratory voxel-level heatmaps were generated to visualize high-risk HCC areas. Model performance was summarized using median values and 95% non-parametric confidence intervals. 121 patients (65 ± 9.56; 99 men) were included. The best model performances for LR, RF, and XGB were achieved when training and validating on manual annotations: (AUC [95% CI]: 0.75 [0.72-0.78]; 0.80 [0.78-0.81]; 0.79 [0.77-0.81], respectively). Predictions from LR-3 lesions outperformed regions without visible precursor territory (RF AUC [95% CI]: 0.86 [0.84-0.88] vs. 0.66 [0.63-0.70]). In 36 out of 121 patients (30%), heatmaps showed visually increased probability signals in the region where HCC subsequently became visible on follow-up imaging. The results demonstrate the feasibility of ML-based MRI analysis for identifying liver regions at increased risk for HCC development prior to radiologic diagnosis, particularly in the presence of precursor lesions.
- 28 May 2026
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (6) , 1617-1619
Metabolic reprogramming of the tumor microenvironment during transarterial therapy: Where no catheter has gone before
An abstract is unavailable. This article is available as a PDF only.
- 28 May 2026
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (6) , 1617-1619
Metabolic reprogramming of the tumor microenvironment during transarterial therapy: Where no catheter has gone before
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 5 March 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (7) , 101813
Deep learning-based generation of synthetic multiphasic MRI in hepatocellular carcinoma and cirrhosis
- 5 March 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (7) , 101813
Open AccessDeep learning-based generation of synthetic multiphasic MRI in hepatocellular carcinoma and cirrhosis
- 17 November 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (5) , 1255-1257
Radiomics beyond the visible—Decoding tumor heterogeneity to guide combination therapy of intermediate-stage HCC
- 17 November 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (5) , 1255-1257
Radiomics beyond the visible—Decoding tumor heterogeneity to guide combination therapy of intermediate-stage HCC
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 316 (2) , e242750
Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma
Quantitative multiparametric contrast-enhanced MRI parameters helped predict molecular profiles of hepatocellular carcinoma via machine learning algorithms.
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 316 (2) , e242750
Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma
Quantitative multiparametric contrast-enhanced MRI parameters helped predict molecular profiles of hepatocellular carcinoma via machine learning algorithms.
- 17 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (4) , 536-537
Commentary on: Comparative Analysis of Systemic Immune Responses and Metastatic Risks in Tumor Ablation: An Animal Study of Radiofrequency Ablation and Irreversible Electroporation with Immune Modulation
- 17 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (4) , 536-537
Commentary on: Comparative Analysis of Systemic Immune Responses and Metastatic Risks in Tumor Ablation: An Animal Study of Radiofrequency Ablation and Irreversible Electroporation with Immune Modulation
- 25 February 2025
- Published by Elsevier in Clinical Imaging
- Vol. 120, 110438
Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACE
- 25 February 2025
- Published by Elsevier in Clinical Imaging
- Vol. 120, 110438
Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACE
- Open Access
- 4 December 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (3) , 101294
Molecular MRI of T-cell immune response to cryoablation in immunologically hot vs. cold hepatocellular carcinoma
- 4 December 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (3) , 101294
Open AccessMolecular MRI of T-cell immune response to cryoablation in immunologically hot vs. cold hepatocellular carcinoma